MSC - Page 14

Phase II Trial Shows Promise of Repeated Stem Cell Injections for ALS Treatment

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle paralysis and death, typically within 3-5 years of onset. Despite two FDA-approved therapies, Riluzole, and Edravarone, which offer limited benefits, there remains no cure for ALS.  Considering this, researchers have turned to Mesenchymal stem…

How Regenerative Medicine Has Revolutionized Neurodegenerative Disease Management

Neurodegenerative diseases, which include conditions like amyotrophic lateral sclerosis (ALS), motor neuron disease, stem cell therapy for Parkinson disease’s disease, and stem cell therapy for multiple sclerosis (MS), are characterized by the progressive loss of structure and function of neurons. These conditions are currently considered incurable and utilize treatments focusing primarily on managing symptoms rather…

Utilizing Mesenchymal Stem Cells as an Innovative Therapeutic Strategy for Diabetes and Pancreatic Disorders

According to the World Health Organization, an estimated 422 million people worldwide have diabetes. Numerous studies have demonstrated that people with diabetes are at an increased risk of developing both acute and chronic pancreatitis, which increases the risk of developing pancreatic cancer.   Considering the lack of effective therapeutic options for pancreatitis and the limited treatment…

Reviewing The Effectiveness of Stem Cell Therapies in Managing Neuropathic Pain

The International Association for the Study of Pain defines neuropathic pain as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system”. While general neuropathy is diverse by nature, neuropathic lesions generally fall into four categories: focal or multifocal lesions of the peripheral system, general lesions of the peripheral nervous…

Regenerative Medicine Options for Neuropathy Pain Management

Neuropathic pain is pain caused as part of a dysfunction in the nervous system, including the peripheral nerves, brain, and spinal cord. Often characterized by spontaneous pain occurring for no specific reason, neuropathic pain can range from mild to severe and is currently estimated to affect 150 million people in the United States. The risk…

Mesenchymal Stem Cells for Managing Spinal Cord Injuries

Nerve damage resulting from stem cell therapy for spinal cord injury (SCI) often leads to temporary or permanent loss of function and contributes to poor quality of life. Most common among males below 30 years of age, SCI recovery has been limited specifically as a result of the low growth capacity of neurons and a…

Utilizing Mesenchymal Stem Cells for Spinal Cord Injury Therapy

Spinal cord injuries (SCI) are the most serious complication associated with spinal injuries and often result in permanent damage to the nervous system. With nearly 300,000 people in the United States living with SCI, the inability to treat these injuries has a significant impact on physical, mental, and financial health.  Additionally, while 94% of those…

The Healing Benefits of Mesenchymal Stem Cells in Skin Inflammatory Conditions of Atopic Dermatitis and Psoriasis

Chronic skin inflammatory diseases, including atopic dermatitis (AD) and psoriasis, are considered uncontrolled responses to systemic inflammation. Characterized by swelling, irritation, and rash chronic skin inflammatory disease, these common skin inflammatory diseases are estimated to affect 25% of the population, with AD and psoriasis being the most common form of the disease. Recent methods used…

Phase 1 Clinical Trial Investigating the Use of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Traumatic Spinal Cord Injury

With more than 17,000 people in the US sustaining a spinal cord injury (SCI) each year and an estimated combined cost to healthcare and the workforce exceeding $40 billion, the condition has significant personal and socioeconomic implications. In addition, SCIs have limited pharmacological treatment options to support the regeneration of nerve damage. Considering the limited…

The Safety and Effectiveness of Stem Cell Treatment as an Emerging Approach for ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of upper and lower motor neurons resulting in paralysis, respiratory insufficiency, difficulties speaking and swallowing, stiffness and spasticity, and muscle atrophy. Commonly known as Lou Gehrig’s disease, after the baseball player was diagnosed with it, ALS is diagnosed in an estimated 5,000 Americans…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.